A carcinoma-killing virus is being used as a delivery system for a protein that can specifically target cells surrounding and protecting tumors.
Browsing: nonsurgical treatment
Hapreet Wasan discusses the tumor biology of pancreatic cancer, the potential role of the enzyme asparaginase in treating these cancers, and what advancements he hopes to see in the coming years.
In a recent Phase II trial involving 35 patients with tumors with AKT mutations capivasertib, an AKT inhibitor, has demonstrated signs of effectiveness.
Authors discuss the results of this observational real-world study and how sequencing tyrosine kinase inhibitors can extend chemotherapy-free treatment time.
ESMO WCGI: Study highlights how liquid biopsy’s provide insight into why some cancer treatments lose effectiveness
Researchers have highlighted the potential of liquid biopsy’s ability to further our understanding of why in some individuals, cancer treatments lose effectiveness.
In the oncology setting there is a significant challenge in understanding the comparative effectiveness of individual agents and the optimal order to administer those agents – this opinion article presents a novel method to evaluate the comparative effectiveness of oncology treatment sequences.
Systemic therapy options for advanced gastrointestinal stromal tumors beyond first-line imatinib: a systematic review
This article provides a thorough assessment of the available evidence for systemic therapy options for patients with advanced gastrointestinal stromal tumors beyond first-line imatinib.
Recent research has determined that suspected lung cancer sufferers wait too long to receive treatment and many skip important diagnostic tests.
Endocrine therapies for breast cancer are highly impacted by nonadherence of patients. How can this be overcome?
Nonsurgical multidisciplinary approach for recurrent hepatocellular carcinoma after surgical resection
This review summarises the current evidence for nonsurgical treatments of recurrent HCC after resection and suggests a multidisciplinary approach to improving the prognosis of recurrent HCC.